Janus Henderson Group Plc - Mar 31, 2025 SCHEDULE 13G/A Report for TENAX THERAPEUTICS, INC. Common Stock (TENX)

Filing Manager
JANUS HENDERSON GROUP PLC
Reporting Manager
JANUS HENDERSON GROUP PLC
Security
TENAX THERAPEUTICS, INC. Common Stock
Symbol
TENX
Shares outstanding
4.01M shares
Disclosed Ownership
397K shares
Ownership
9.9%
Form type
SCHEDULE 13G/A
Date filed
5/14/2025, 12:50 PM
Date of event
Mar 31, 2025
Previous filing
Feb 14, 2025
Next filing
Aug 14, 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
JANUS HENDERSON GROUP PLC 9.9% 397K 0 397K Kristin Mariani Head of North America Compliance, CCO
Janus Henderson Biotech Innovation Master Fund Ltd 9.9% 397K 0 397K Kristin Mariani Head of North America Compliance, CCO